The overwhelming trader consensus against invoking the 25th Amendment to remove President Trump before 2027 reflects the absence of any reported incapacity, ongoing health concerns, or cabinet-level action, combined with Republican majorities in Congress that would need to support any such process. Historical precedent shows the amendment has rarely been used for involuntary removal, and no recent developments—such as medical disclosures, official statements, or legislative moves—suggest grounds for its application in the current term. While sudden health events, unforeseen scandals, or shifts in administration dynamics could theoretically alter the outlook, the lack of credible catalysts through mid-2026 underpins the market's assessment of near-certainty that removal will not occur.